Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase ...

Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase I, multicenter, single-arm, open-label study | Cell Discovery  Nature

What We Know from the Latest PEPFAR Data: Analysis of FY 2025 Quarter 4 Results - KFF

What We Know from the Latest PEPFAR Data: Analysis of FY 2025 Quarter 4 Results  KFF

WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls - World Health...

WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls  World Health Organization (WHO)

A Potential Cure for AIDS: Defeating HIV With a Single Injection - SciTechDaily

A Potential Cure for AIDS: Defeating HIV With a Single Injection  SciTechDaily

Monthly HIV injection could free patients from gruelling drug regimen - Nature

Monthly HIV injection could free patients from gruelling drug regimen  Nature

How an Indian tycoon fought Big Pharma to sell AIDS drugs for $1 a day - qz.com

How an Indian tycoon fought Big Pharma to sell AIDS drugs for $1 a day  qz.com

Myanmar on brink of HIV treatment crisis - Frontier Myanmar

Myanmar on brink of HIV treatment crisis  Frontier Myanmar

Genetically engineered white blood cells could be the future of HIV treatment - The Verge

Genetically engineered white blood cells could be the future of HIV treatment  The Verge

Lenacapavir shows continued promise for first-line treatment and highly resistant HIV (Mandarin) ...

Lenacapavir shows continued promise for first-line treatment and highly resistant HIV (Mandarin)  Aidsmap

Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates | Gene Thera...

Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates | Gene Therapy  Nature